These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease. Gomez G Front Immunol; 2019; 10():175. PubMed ID: 30792720 [TBL] [Abstract][Full Text] [Related]
9. Improved FcγRIIb targeting functionally translates into enhanced inhibition of basophil activation. Buschor P; Eggel A; Zellweger F; Stadler BM; Vogel M Int Arch Allergy Immunol; 2014; 163(3):206-14. PubMed ID: 24557487 [TBL] [Abstract][Full Text] [Related]
10. Distinct Contributory Factors Determine Basophil-Allergen Sensitivity in Grass Pollen Rhinitis and in Anaphylactic Wasp Venom Allergy. Korošec P; Šilar M; Kopač P; Eržen R; Zidarn M; Košnik M Int Arch Allergy Immunol; 2016; 171(2):89-101. PubMed ID: 27907922 [TBL] [Abstract][Full Text] [Related]
11. CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation. Sabato V; Verweij MM; Bridts CH; Levi-Schaffer F; Gibbs BF; De Clerck LS; Schiavino D; Ebo DG Cytometry B Clin Cytom; 2012 May; 82(3):132-8. PubMed ID: 22173928 [TBL] [Abstract][Full Text] [Related]
12. Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis. Imamura S; Washio K; Mizuno M; Oda Y; Fukunaga A; Nishigori C Allergol Int; 2021 Jul; 70(3):327-334. PubMed ID: 33674191 [TBL] [Abstract][Full Text] [Related]
13. Roles for the High Affinity IgE Receptor, FcεRI, of Human Basophils in the Pathogenesis and Therapy of Allergic Asthma: Disease Promotion, Protection or Both? Youssef LA; Schuyler M; Wilson BS; Oliver JM Open Allergy J; 2010; 3():91-101. PubMed ID: 25018787 [TBL] [Abstract][Full Text] [Related]
15. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb. Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932 [TBL] [Abstract][Full Text] [Related]
16. FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy. Berings M; Gevaert P; De Ruyck N; Derycke L; Holtappels G; Pilette C; Bachert C; Lambrecht BN; Dullaers M Clin Exp Allergy; 2018 Aug; 48(8):970-980. PubMed ID: 29682789 [TBL] [Abstract][Full Text] [Related]
17. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils. Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998 [TBL] [Abstract][Full Text] [Related]
18. The anti-IgE/anti-FcepsilonRIalpha autoantibody network in allergic and autoimmune diseases. Marone G; Spadaro G; Palumbo C; Condorelli G Clin Exp Allergy; 1999 Jan; 29(1):17-27. PubMed ID: 10051698 [TBL] [Abstract][Full Text] [Related]
19. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils. Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of ongoing allergic reactions using a novel anti-IgE DARPin-Fc fusion protein. Eggel A; Buschor P; Baumann MJ; Amstutz P; Stadler BM; Vogel M Allergy; 2011 Jul; 66(7):961-8. PubMed ID: 21272035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]